Author

Maren Prüfer

Observed names: M Prüfer, Prüfer, Maren

Institution: Georg Speyer Haus

Observed institution: Georg Speyer Haus

ORCID: 0009-0001-9329-8656

Observed ORCID: 0009-0001-9329-8656

OpenAlex ID: A5013294512

ErbB2/HER2-targeted CAR-NK cells eliminate breast cancer cells in an organoid model that recapitulates tumor progression

2025 · Jasmin Röder, Tijna Alekseeva, et al. · Molecular Therapy · 23

Dual Targeting of Glioblastoma Cells with Bispecific Killer Cell Engagers Directed to EGFR and ErbB2 (HER2) Facilitates Effective Elimination by NKG2D-CAR-Engineered NK Cells

2024 · Anne Kiefer, Maren Prüfer, et al. · Cells · 20

Multivalent adaptor proteins specifically target NK cells carrying a universal chimeric antigen receptor to ErbB2 (HER2)-expressing cancers

2023 · Jordi Pfeifer Serrahima, Congcong Zhang, et al. · Cancer Immunology Immunotherapy · 10

Bispecific killer cell engagers employing species cross-reactive NKG2D binders redirect human and murine lymphocytes to ErbB2/HER2-positive malignancies

2024 · Jordi Pfeifer Serrahima, Katrin Schoenfeld, et al. · Frontiers in Immunology · 9

Empowering Natural Killer Cells to Combat Acute Myeloid Leukemia: Perspective on CAR-NK Cell Therapy

2024 · Fenja Gierschek, Juliane Schlueter, et al. · Transfusion Medicine and Hemotherapy · 5

In vitro and in vivo comparison of VHH- and scFv-based CLEC12A-chimeric antigen receptor-natural killer cells against acute myeloid leukemia

2025 · F Gierschek, P Wendel, et al. · Klinische Pädiatrie

Engineering multifunctional GRP78-CAR CIK cells to target relapsed/refractory pediatric AML

2024 · E Hopke, R Bhayadia, et al. · Klinische Pädiatrie

Works count: 8

Citation count: 67

H-index: 5

I10-index: 3